Journal News

JBC: Researchers link
new protein to Parkinson’s

Laurel Oldach
Oct. 1, 2019

Researchers in Japan are reporting new insight into how the Parkinson’s disease-associated protein parkin selects its targets. The finding might improve experimental therapies for Parkinson’s that aim to boost parkin activity.

This image of cells with damaged mitochondria shows overlap
Koyano et al./JBC 2019
This image of cells with damaged mitochondria shows overlap, in yellow, between parkin protein in green and the mitochondria, shown in red.

Cells depend on parkin to help get rid of damaged mitochondria. The research, published in the Journal of Biological Chemistry, suggests that parkin depends on other proteins, including one called MITOL that has not been linked previously to Parkinson’s disease, to direct it to those damaged mitochondria.

Parkin adds a degradation tag called ubiquitin to proteins on the mitochondrial surface. In some patients with familial Parkinson’s disease, parkin activity is disrupted and bad mitochondria cannot be destroyed. Harmful byproducts from those bad mitochondria can damage neurons. By understanding how parkin works and what goes wrong when it’s mutated, researchers hope also to help patients with other forms of Parkinson’s disease.

While other ubiquitin-tagging proteins, known as E3 ligases, recognize specific amino acid sequences on their substrates, parkin has many known substrates that don’t seem to share a sequence in common. While studying how parkin chooses its substrates, researchers led by Fumika Koyano in Noriyuki Matsuda’s lab at the Tokyo Metropolitan Institute of Medical Science discovered that parkin can tag any lysine-containing protein with ubiquitin — even a bacterial protein not ordinarily found in the cell — as long as it’s present at the surface of the mitochondria.

“Parkin is not regulated by its substrate specificity,” Koyano said of the finding. Instead, control of parkin activity comes from how it is recruited and activated by other proteins.

The discovery that activated parkin is not terribly selective led Koyano and her colleagues to take a closer look at parkin’s recruitment and activation. Some details of that process are well known; for example, a protein called PINK1 is known to boost parkin activity. But Koyano and colleagues discovered a new step that must happen before PINK1 can contribute to parkin activation. They found that parkin acts more rapidly when a first ubiquitin molecule is already present, acting as a seed for the addition of more ubiquitins. In most cases, the researchers found, this seed ubiquitin is added by a protein called MITOL, which had not been linked previously to Parkinson’s.

The research could contribute to the design of new drugs, some of which aim to boost parkin activity to slow the advance of Parkinson’s disease.

“If we achieve upregulation of seed ubiquitylation on mitochondria,” Koyano said, “it might accelerate parkin recruitment and parkin activation to eliminate damaged mitochondria more efficiently.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Laurel Oldach

Laurel Oldach is a science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

From the journals: MCP
Journal News

From the journals: MCP

Aug. 12, 2022

Analysis of large samples of proteins just got an upgrade. Read about the latest breakthroughs in proteomics in these papers from the journal Molecular & Cellular Proteomics.

Is location everything?
Journal News

Is location everything?

Aug. 9, 2022

A lab at the University of Illinois Chicago develops site-specific tools to probe the cellular function of cholesterol.

Did gonorrhea give us grandparents?
News

Did gonorrhea give us grandparents?

Aug. 9, 2022

UC San Diego researchers track evolution of gene variant that supports cognitive health in older humans but may have first emerged to protect against bacteria.

Why researchers are studying menstrual blood
News

Why researchers are studying menstrual blood

Aug. 7, 2022

Some scientists are challenging the conventional view that menstrual effluent is merely a waste product.

From the journals: JBC
Journal News

From the journals: JBC

Aug. 5, 2022

Defining functional redundancy in mycobacteria. Finding aqueous pores in sodium channels. Identifying new substrates for a ubiquitin ligase. Read about papers on these topics.

Cannabis hyperemesis and the cure that burns
Feature

Cannabis hyperemesis and the cure that burns

Aug. 3, 2022

When chronic users of marijuana show up in the ER with uncontrollable vomiting, physicians have a salve that can relieve their pain. Scientists aren’t sure why it works.